K.I. Pritchard
- Oncology top 5%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 10%
- Pulmonary and Respiratory Medicine
- Genetics top 10%
- Co-authors
- Clifford A. HudisRobert W. CarlsonTimothy J. WhelanMark LevineTom OliverRobert E. MyersMary JohnstonKaren A. Gelmon
- Topics
- Breast Cancer Treatment Studies (20 papers)Cancer Treatment and Pharmacology (11 papers)HER2/EGFR in Cancer Research (10 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
K.I. Pritchard
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 72
- Oncology 682
- Cancer Research 580
- Pathology and Forensic Medicine 214
- Pulmonary and Respiratory Medicine 184
- Genetics 183
Countries citing papers authored by K.I. Pritchard
This map shows the geographic impact of K.I. Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.I. Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.I. Pritchard more than expected).
Fields of papers citing papers by K.I. Pritchard
This network shows the impact of papers produced by K.I. Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.I. Pritchard. The network helps show where K.I. Pritchard may publish in the future.
Co-authorship network of co-authors of K.I. Pritchard
This figure shows the co-authorship network connecting the top 25 collaborators of K.I. Pritchard. A scholar is included among the top collaborators of K.I. Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.I. Pritchard. K.I. Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 21 | |
| 3 | 1 | |
| 4 | 93 | |
| 5 | 11 | |
| 6 | 2 | |
| 7 | 12 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 177 | |
| 11 | 81 | |
| 12 | 103 | |
| 13 | 106 | |
| 14 | 8 | |
| 15 | Baseline staging tests in primary breast cancer: a practice guideline. | 91 |
| 16 | 42 | |
| 17 | 16 | |
| 18 | 9 | |
| 19 | 44 | |
| 20 | Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study. | 21 |
About K.I. Pritchard
K.I. Pritchard is a scholar working on Cancer Research, Oncology and Genetics, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), Cancer Treatment and Pharmacology (11 papers) and HER2/EGFR in Cancer Research (10 papers). The work is most often cited by research in Cancer Research (580 citations), Oncology (682 citations) and Pathology and Forensic Medicine (214 citations). K.I. Pritchard has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Clifford A. Hudis, Robert W. Carlson, Timothy J. Whelan, Mark Levine, Tom Oliver, Robert E. Myers, Mary Johnston, Karen A. Gelmon, Wendy R. Parulekar and Maureen Trudeau. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.